Genome Medical is making genetics care accessible and actionable for patients through seven-day-a-week access to genetic services. By partnering with health systems, molecular testing laboratories and ...
As accountable care organizations (ACOs) and pay-for-performance reimbursement models take on greater prominence, the ability to leverage clinical data is emerging as a key tool in reducing costs and ...
Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...
A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...
Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...
Medical learners in the 21st century spend less time with patients during training than their counterparts did in the 20th century, which decreases the knowledge and practice of bedside clinical ...
Hosted on MSN
Opinion: FDA should judge drugs on what they do in real life, not just in companies’ clinical trials
Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback